PW Medtech Group Limited (FRA:PWE)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Blood Purification	522.87M
Blood Purification Growth	20.09%
Infusion Set	310.79M
Infusion Set Growth	0.07%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Other	49.89M
Other Growth	46.28%
China	698.17M
China Growth	4.22%
India	43.01M
India Growth	59.10%
Americas (excluding United States)	22.95M
Americas (excluding United States) Growth	53.62%
Africa	19.64M
Other	49.89M
Other Growth	46.28%